Pfizer Or AbbVie For Better Returns?
- Thursday, June 25, 2020, 7:33
- Market
- Add a comment
Pfizer’s stock has declined by 11% since early February after the WHO declared the coronavirus a global health emergency, while AbbVie’s stock has fared much better and gained 22%. The lockdown in various parts of the world has had a negative impact on the pharmaceuticals industry worldwide…
About the Author
admin123 has written 23434 stories on this site.
